<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The detection of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) can be challenging </plain></SENT>
<SENT sid="1" pm="."><plain>Confocal laser endomicroscopy (CLE) allows in vivo visualization of mucosal histology during endoscopy </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: To determine whether CLE with optical biopsy and targeted mucosal biopsy improves the diagnostic yield of endoscopically inapparent, BE-associated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> compared to standard endoscopy with a 4-quadrant, random biopsy protocol </plain></SENT>
<SENT sid="3" pm="."><plain>DESIGN: Prospective, double-blind, randomized, crossover study </plain></SENT>
<SENT sid="4" pm="."><plain>SETTING: Single, tertiary-care academic center </plain></SENT>
<SENT sid="5" pm="."><plain>PATIENTS: This study involved patients with BE undergoing routine surveillance or referred for treatment of nonlocalized, endoscopically inapparent, BE-associated <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>INTERVENTION: <z:hpo ids='HP_0000001'>All</z:hpo> participants underwent both a confocal endomicroscopy with a targeted biopsy procedure and standard endoscopy with a 4-quadrant biopsy procedure in a randomized order </plain></SENT>
<SENT sid="7" pm="."><plain>MAIN OUTCOME MEASUREMENTS: Increase in diagnostic yield for <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, reduction in mucosal biopsy number, final pathologic diagnosis </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: CLE with targeted biopsy almost doubled the diagnostic yield for <z:hpo ids='HP_0002664'>neoplasia</z:hpo> and was equivalent to the standard protocol for the final diagnosis of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Two thirds of patients in the surveillance group did not need any mucosal biopsies at <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>LIMITATION: Single-center study </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: CLE with targeted biopsy significantly improves the diagnostic yield for endoscopically inapparent BE <z:hpo ids='HP_0002664'>neoplasia</z:hpo> compared to a standard endoscopy with a random-biopsy protocol </plain></SENT>
<SENT sid="12" pm="."><plain>CLE with targeted biopsy also greatly reduces the number of biopsies needed per patient and allows some patients without <z:hpo ids='HP_0002664'>neoplasia</z:hpo> to completely forgo mucosal biopsy </plain></SENT>
</text></document>